Catalytic Health

Dialogues in Cytomegalovirus I N T H I S I S S U E : CMV Management in the Post-DNA Polymerase Inhibitor Era Matthew P. Cheng, MD, FRCPC A Case-Based Approach to CMV Management Zain Chagla, MD, FRCPC J U N E 2 0 2 3

• Cover
• CMV Management in the Post-DNA Polymerase Inhibitor Era
• Matthew P. Cheng, MD
• A Case-Based Approach to CMV Management
• Zain Chagla, MD